Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chloride channel CLIC-like protein 1 (CLCC1) is an ER-localized intracellular chloride ion channel critical for maintaining chloride homeostasis and calcium balance within the endoplasmic reticulum[1][3][2]. CLCC1 participates in proper protein folding, regulation of the unfolded protein response, and inter-organelle communication at ER-mitochondria contact sites[1][2]. Loss or mutation of CLCC1 impairs ER ion homeostasis, leading to ER stress, misfolded protein accumulation, cell death, and diseases such as autosomal recessive retinitis pigmentosa (RP32) and neurodegeneration[1][2][3]. In the pancreas, CLCC1 is required for β-cell function and insulin production, implicating it in glucose metabolism disorders[4]. No approved drugs target CLCC1, but loss-of-function mutations or disruption of activity reveal its importance in diseases with neuronal, retinal, or endocrine (islet) pathologies[1][2][3][4].
No known drugs; mechanistically, antagonism would disrupt ER chloride flux, alter Ca²⁺ homeostasis, cause ER stress, and cell death
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chloride channel CLIC-like protein 1 (CLCC1).